thyroxine and Non-alcoholic Fatty Liver Disease studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

Excerpt	Relevance	Reference
"The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear."	8.12	Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022)
"Non-alcoholic fatty liver disease (NAFLD) has become a major public health problem concern in recent decades."	5.72	Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people. ( Cheng, Q; Shao, C; Xiang, X; Xu, Y; Zhang, S, 2022)
"NAFLD was diagnosed by ultrasound."	5.51	Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019)
"NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD."	5.46	Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017)
"The relationship between FT4 and NAFLD in women was different according to menopausal status, with negative association in pre-menopausal women (OR: 0."	5.42	Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015)
" Hypothyroidism has been identified as a risk factor for NAFLD as thyroxine is required for regulating metabolism in adults."	5.41	Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. ( Li, L; Shi, Y; Song, Y; Sun, L, 2023)
"Overweight/obesity mediated the associations of MAFLD with triiodothyronine (T3), free triiodothyronine (FT3), free thyroxine (FT4), and the mediator accounted for 46."	4.31	The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. ( Cao, L; Chen, X; Fan, H; Li, L; Liu, Z; Suo, C; Zhang, T, 2023)
"The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear."	4.12	Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022)
" Based on their initial serum-free thyroxine (fT4) and thyroid-stimulating hormone (TSH) levels, they were classified into control, subclinical hypothyroidism (TSH >4."	3.81	Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study. ( Bang, KB; Cho, YK; Kwon, HJ; Lee, KW; Lee, MY; Rhee, EJ, 2015)
"Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and associated with significant morbidity and mortality."	2.87	Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD. ( Angus, PW; Bee, YM; Bruinstroop, E; Burrell, LM; Cao, Y; Chandran, K; Cho, LW; Dalan, R; Leow, MKS; Leung, C; Lim, SC; Michael, N; Patel, SK; Sadananthan, SA; Sinha, RA; Soh, SB; Stapleton, HM; Sum, CF; Teo, EK; Toh, SA; Velan, SS; Yen, PM, 2018)
"Non-alcoholic fatty liver disease (NAFLD) has become a major public health problem concern in recent decades."	1.72	Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people. ( Cheng, Q; Shao, C; Xiang, X; Xu, Y; Zhang, S, 2022)
"In subjects with liver fibrosis, other cause of liver fibrosis were ruled out."	1.72	Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine. ( Arturi, F; Aversa, A; Brunetti, A; Mazza, E; Montalcini, T; Perticone, M; Pujia, A; Pujia, R; Romeo, S; Sciacqua, A, 2022)
"In sufferers with nonalcoholic fatty liver disease (NAFLD), the differences of thyroid associated hormones and neutrophil to lymphocyte ratio (NLR) in different liver pathological groups have been compared."	1.72	Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease. ( Chu, W; Feng, J; Li, P; Liu, L; Liu, Y; Mi, Y; Niu, B; Wu, X; Zhang, P, 2022)
"The incidence rate of NAFLD was 85."	1.72	High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. ( Gu, Y; Jia, Q; Liu, L; Meng, G; Niu, K; Song, K; Sun, S; Wang, X; Wang, Y; Wu, H; Wu, X; Zhang, Q; Zhang, S; Zhang, T; Zhou, M, 2022)
"Thyroid function and type 2 diabetes mellitus (T2DM) are both associated with increased risks of adverse clinical outcomes in nonalcoholic fatty liver disease (NAFLD)."	1.56	Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. ( Huang, B; Yang, S; Ye, S, 2020)
"Serum FT3 levels in subjects with NAFLD were significantly reduced, while TSH was increased compared to that in controls."	1.56	Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population. ( Dai, Y; Qin, J; Zhang, J; Zhang, X, 2020)
"The major outcome was the occurrence of NAFLD, diagnosed based on the findings of abdominal ultrasonography."	1.51	The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. ( Chen, MY; Chen, SY; Chou, YY; Pan, YW; Tsai, MC; Yang, YJ, 2019)
"NAFLD was diagnosed by ultrasound."	1.51	Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019)
"In murine models of advanced nonalcoholic steatohepatitis (NASH), the administration of T3 reduced liver triglyceride, repressed liver inflammation, and attenuated injury."	1.51	Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. ( Bechmann, L; Best, J; Canbay, A; Claridge, LC; Coombes, JD; Gerken, G; Manka, P; Moeller, L; Sydor, S; Syn, WK; Wedemeyer, H, 2019)
"NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD."	1.46	Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017)
"Hypothyroidism was considered at a thyroid stimulating hormone level ≥ 4."	1.43	FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. ( Ahbab, S; Ataoğlu, HE; Çetin, F; Gökmen, FY; Mamaç, RY; Türker, BÇ; Türker, F; Yenigün, M, 2016)
"Subjects with NAFLD had significantly higher TSH levels and lower FT4 levels than those without NAFLD (p < 0."	1.42	Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. ( Gu, H; Sui, J; Tao, Y; Wu, J, 2015)
"The relationship between FT4 and NAFLD in women was different according to menopausal status, with negative association in pre-menopausal women (OR: 0."	1.42	Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015)
"Non-alcoholic fatty liver disease (NAFLD) is one of the most common disorders of the liver worldwide."	1.42	Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. ( Boehm, BO; Denzer, C; Graeter, T; Greinert, A; Haenle, MM; Holzner, D; Koenig, W; Kratzer, W; Ludwig, U; Mason, RA; Oeztuerk, S, 2015)
"NAFLD was diagnosed by conventional ultrasound examination."	1.40	Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. ( Aydın, S; Cesur, Y; Gökçe, S; Özgen, IT; Torun, E, 2014)
"NAFLD and non-NAFLD groups had slightly higher fasting blood glucose values than the control group."	1.40	Thyroid function in obese children with non-alcoholic fatty liver disease. ( Bilgin, H; Pirgon, Ö, 2014)
"NAFLD was significantly associated with hypothyroidism (30."	1.38	Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. ( Chung, GE; Kim, D; Kim, W; Kim, YJ; Lee, HS; Park, MJ; Yim, JY; Yoon, JH, 2012)
"Patients with NAFLD had significantly lower levels of serum-free thyroxine (FT4) than controls (11·12 ± 1·43 vs 11·58 ± 1·47 pmol/l; P < 0·001)."	1.37	Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2011)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	19 (54.29)	24.3611
2020's	16 (45.71)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients[NCT03281083]	Phase 2	29 participants (Actual)	Interventional	2014-03-28	Terminated (stopped due to Difficult recruitment and end of funding.)
Early Predictors of NAFLD in Patient of Hypothyroidism[NCT05813301]		100 participants (Anticipated)	Observational	2023-11-01	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. The Journal of clinical endocrinology and metabolism, 2023, Jun-16, Volume: 108, Issue:7 Topics: Animals; Humans; Hypothyroidism; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Thyroid Hormone	2023
Hepatomegaly and fatty liver disease secondary to central hypothyroidism in combination with macrosomia as initial presentation of IGSF1 deficiency syndrome. Hormones (Athens, Greece), 2023, Volume: 22, Issue:3 Topics: Adult; Congenital Hypothyroidism; Female; Fetal Macrosomia; Hepatomegaly; Humans; Immunoglobulins; I	2023
Enfermedades infecciosas y microbiologia clinica, 2023, Volume: 41, Issue:3 Topics: Adult; China; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver D	2023
Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. European journal of clinical investigation, 2015, Volume: 45, Issue:5 Topics: Asymptomatic Diseases; Cardiovascular Diseases; Cholesterol, LDL; Humans; Hypothyroidism; Insulin Re	2015

Article	Year
Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people. Annals of palliative medicine, 2022, Volume: 11, Issue:2 Topics: Cross-Sectional Studies; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Retrospective Stud	2022
Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function. BMC endocrine disorders, 2022, May-31, Volume: 22, Issue:1 Topics: Diabetes Mellitus, Type 2; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Retrospective	2022
Thyroid Stimulating Hormone Levels Are Associated With Genetically Predicted Nonalcoholic Fatty Liver Disease. The Journal of clinical endocrinology and metabolism, 2022, 08-18, Volume: 107, Issue:9 Topics: Humans; Mendelian Randomization Analysis; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; Thyr	2022
Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine. Medicina (Kaunas, Lithuania), 2022, Jul-18, Volume: 58, Issue:7 Topics: Cross-Sectional Studies; Humans; Hypothyroidism; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver D	2022
Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. Frontiers in endocrinology, 2022, Volume: 13 Topics: Adiposity; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors; Thyroxi	2022
The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:6 Topics: Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thyroid Hormones	2023
Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease. Medicine, 2022, Dec-23, Volume: 101, Issue:51 Topics: Fibrosis; Humans; Lymphocytes; Neutrophils; Non-alcoholic Fatty Liver Disease; Thyroid Gland; Thyroi	2022
Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease. The Journal of clinical endocrinology and metabolism, 2023, Jun-16, Volume: 108, Issue:7 Topics: Cardiovascular Diseases; Humans; Hypothyroidism; Non-alcoholic Fatty Liver Disease; Nutrition Survey	2023
The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease. Frontiers in endocrinology, 2023, Volume: 14 Topics: Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Thyroid G	2023
Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults. The Journal of clinical endocrinology and metabolism, 2023, 08-18, Volume: 108, Issue:9 Topics: Adult; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Prospective Studies; Risk Factors	2023
The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. The Kaohsiung journal of medical sciences, 2019, Volume: 35, Issue:12 Topics: Adolescent; Adult; Blood Glucose; Child; Congenital Hypothyroidism; Cross-Sectional Studies; Female;	2019
Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. Journal of diabetes research, 2020, Volume: 2020 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-a	2020
Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population. Clinical laboratory, 2020, Oct-01, Volume: 66, Issue:10 Topics: China; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Ri	2020
High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. The journals of gerontology. Series A, Biological sciences and medical sciences, 2022, 01-07, Volume: 77, Issue:1 Topics: Aged; Cohort Studies; Humans; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; T	2022
Turner syndrome as a cause of liver cirrhosis. Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:5 Topics: Estrogens; Female; Gilbert Disease; Hashimoto Disease; Hormone Replacement Therapy; Human Growth Hor	2018
Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. European journal of clinical investigation, 2019, Volume: 49, Issue:4 Topics: Alanine Transaminase; Cross-Sectional Studies; Disease Progression; Female; Humans; Liver Cirrhosis,	2019
Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone. Current molecular pharmacology, 2019, Volume: 12, Issue:2 Topics: Animals; Bile; Diet, High-Fat; Glucagon-Like Peptide 1; Liver; Male; Methimazole; Mice; Mice, Inbred	2019
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. Digestive diseases and sciences, 2019, Volume: 64, Issue:8 Topics: Biomarkers; Down-Regulation; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty	2019
Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. Journal of clinical research in pediatric endocrinology, 2014, Volume: 6, Issue:1 Topics: Adolescent; Anthropometry; Biomarkers; Case-Control Studies; Child; Fatty Liver; Female; Follow-Up S	2014
Thyroid function in obese children with non-alcoholic fatty liver disease. Journal of clinical research in pediatric endocrinology, 2014, Volume: 6, Issue:3 Topics: Adolescent; Biomarkers; Blood Glucose; Case-Control Studies; Child; Female; Humans; Insulin; Insulin	2014
Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. Endocrine research, 2015, Volume: 40, Issue:2 Topics: Adult; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic	2015
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. Endocrine research, 2015, Volume: 40, Issue:4 Topics: Adult; China; Comorbidity; Female; Humans; Male; Menopause; Metabolic Syndrome; Middle Aged; Non-alc	2015
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. BMC endocrine disorders, 2015, Aug-15, Volume: 15 Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cross-Secti	2015
Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study. Clinical and molecular hepatology, 2015, Volume: 21, Issue:4 Topics: Adult; Aged; Cohort Studies; Female; Follow-Up Studies; Humans; Hypothyroidism; Incidence; Kaplan-Me	2015
FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics (Sao Paulo, Brazil), 2016, Volume: 71, Issue:4 Topics: Adult; Biomarkers; Cholesterol; Female; Humans; Hypothyroidism; Insulin Resistance; Male; Metabolic	2016
Thyroid function: Poor thyroid function linked to NAFLD. Nature reviews. Endocrinology, 2016, Volume: 12, Issue:8 Topics: Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Thyroid Function Tests; Thyroid Gland; Thyro	2016
Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. Metabolism: clinical and experimental, 2017, Volume: 67 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Female; Humans;	2017
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clinical endocrinology, 2011, Volume: 75, Issue:2 Topics: Aged; Asian People; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Humans; Non-alcoholic Fat	2011
Setpoints and susceptibility: do small differences in thyroid function really matter? Clinical endocrinology, 2011, Volume: 75, Issue:2 Topics: Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Thyroid Gland; Thyroxine	2011
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. Journal of hepatology, 2012, Volume: 57, Issue:1 Topics: Adult; Alanine Transaminase; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Female; Humans;	2012

thyroxine and Non-alcoholic Fatty Liver Disease

Research Excerpts

Research

Studies (35)

Authors

Clinical Trials (2)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Shao, C	1
Cheng, Q	1
Zhang, S	2
Xiang, X	2
Xu, Y	2
Zhang, Y	5
Li, J	1
Liu, H	1
Fan, H	2
Liu, Z	2
Zhang, X	5
Wu, S	1
Shi, T	1
Zhang, P	2
Chen, X	3
Zhang, T	3
Pujia, R	1
Mazza, E	1
Montalcini, T	1
Arturi, F	1
Brunetti, A	1
Aversa, A	1
Romeo, S	1
Perticone, M	1
Sciacqua, A	1
Pujia, A	1
Liu, HX	1
Ren, YY	1
Meng, CQ	1
Li, Z	2
Nie, Q	1
Yu, CH	1
Ma, HJ	1
Li, L	3
Cao, L	1
Suo, C	1
Li, P	1
Liu, L	4
Niu, B	1
Mi, Y	1
Liu, Y	1
Feng, J	1
Wu, X	2
Chu, W	1
Chen, YL	1
Tian, S	1
Wu, J	3
Li, H	3
Li, S	1
Xu, Z	2
Liang, XY	1
Adhikari, VP	1
Xiao, J	1
Song, JY	1
Ma, CY	1
She, RL	1
Li, ZX	1
Wu, KN	1
Kong, LQ	1
Song, Y	1
Shi, Y	1
Sun, L	1
Hu, Y	1
Zhou, F	1
Lei, F	1
Lin, L	1
Huang, X	1
Sun, T	1
Liu, W	1
Cai, J	1
She, ZG	1
Wan, H	1
Yu, G	1
Xu, S	1
Jiang, Y	1
Duan, H	1
Lin, X	1
Ma, Q	1
Wang, D	1
Liang, Y	1
Shen, J	1
Nikolaou, M	1
Vasilakis, IA	1
Marinakis, NM	1
Tilemis, FN	1
Zellos, A	1
Lykopoulou, E	1
Traeger-Synodinos, J	1
Kanaka-Gantenbein, C	1
Pan, YW	1
Tsai, MC	1
Yang, YJ	1
Chen, MY	1
Chen, SY	1
Chou, YY	1
Huang, B	1
Yang, S	1
Ye, S	1
Zhang, J	2
Dai, Y	1
Qin, J	1
Gu, Y	1
Zhang, Q	2
Meng, G	1
Wu, H	1
Wang, Y	4
Wang, X	2
Sun, S	1
Zhou, M	1
Jia, Q	1
Song, K	1
Niu, K	1
Quirós-González, V	1
Rubio, R	1
Pulido, F	1
Rial-Crestelo, D	1
Martín-Jurado, C	1
Hernández-Ros, MÁ	1
López-Jiménez, EA	1
Ferrari, JM	1
Caro-Teller, JM	1
Pinar, Ó	1
Pedrera-Jiménez, M	1
García-Barrio, N	1
Serrano, P	1
Bernal, JL	1
Tanguay, P	1
Décary, S	1
Martineau-Roy, J	1
Gravel, EM	1
Gervais, I	1
St-Jean, P	1
Tousignant, M	1
Marquis, N	1
Qian, L	1
Xuemei, L	1
Jitao, L	1
Yun'Ai, S	1
Tianmei, S	1
da Silva, HS	1
Nakamura, FY	1
Papoti, M	1
da Silva, AS	1
Dos-Santos, JW	1
Huth, SF	1
Cho, SM	1
Robba, C	1
Highton, D	1
Battaglini, D	1
Bellapart, J	1
Suen, JY	1
Li Bassi, G	1
Taccone, FS	1
Arora, RC	1
Whitman, G	1
Fraser, JF	1
Fanning, JP	1
Yang, B	1
Dmytriw, AA	1
Wang, T	1
Luo, J	1
Li, Y	2
Ma, Y	1
Chen, J	1
Gao, P	1
Feng, Y	1
Bai, X	1
Dong, J	1
Yang, R	1
Jiao, L	2
Ling, F	1
Ding, Y	1
Chen, Z	1
Pan, Y	1
Wang, J	1
Meng, X	1
Lin, J	1
Jing, J	1
Xie, X	1
Lwi, SJ	1
Herron, TJ	1
Curran, BC	1
Ivanova, MV	1
Schendel, K	1
Dronkers, NF	1
Baldo, JV	1
Yi, X	1
Yang, Y	1
Zhao, Z	2
Xu, M	1
Sheng, Y	1
Tian, J	1
Hua, W	1
Peng, Y	1
Han, Z	1
Li, T	2
Yin, C	1
Wang, S	1
Nan, G	1
Yang, H	1
Zhou, B	1
Cai, Y	1
Li, G	1
Peng, X	1
Guan, S	1
Zhou, J	1
Ye, M	1
Wang, L	1
Zhang, L	1
Hong, B	1
Wan, J	1
Zhu, Q	1
Liu, J	1
Yang, P	1
Guido, CA	1
Loffredo, L	1
Zicari, AM	1
Pavone, P	1
Savasta, S	1
Gagliano, A	1
Brindisi, G	1
Galardini, G	1
Bertolini, A	1
Spalice, A	1
Zheng, S	1
Wang, H	2
Chen, G	1
Shangguan, H	1
Yu, L	1
Lin, Z	1
Lin, Y	1
Yao, P	1
Kang, D	1
Guo, W	1
Qin, P	1
Li, XN	1
Lu, J	1
Zhu, WF	1
Diao, QQ	1
Xu, NZ	1
Machlab, S	1
Miquel, M	1
Voltà, T	1
Escoda, MR	1
Vergara, M	1
Bruinstroop, E	1
Dalan, R	1
Cao, Y	1
Bee, YM	1
Chandran, K	1
Cho, LW	1
Soh, SB	1
Teo, EK	1
Toh, SA	1
Leow, MKS	1
Sinha, RA	1
Sadananthan, SA	1
Michael, N	1
Stapleton, HM	1
Leung, C	1
Angus, PW	1
Patel, SK	1
Burrell, LM	1
Lim, SC	1
Sum, CF	1
Velan, SS	1
Yen, PM	1
Chen, P	1
Hou, X	1
Wei, L	1
Feng, L	1
Zhong, L	1
Bao, Y	1
Jia, W	1
Patel, VJ	1
Joharapurkar, AA	1
Kshirsagar, SG	1
Sutariya, BK	1
Patel, MS	1
Bahekar, RH	1
Jain, MR	1
Manka, P	1
Bechmann, L	1
Best, J	1
Sydor, S	1
Claridge, LC	1
Coombes, JD	1
Canbay, A	1
Moeller, L	1
Gerken, G	1
Wedemeyer, H	1
Syn, WK	1
Torun, E	1
Özgen, IT	1
Gökçe, S	1
Aydın, S	1
Cesur, Y	1
Bilgin, H	1
Pirgon, Ö	1
Tao, Y	1
Gu, H	1
Sui, J	1
Liu, G	1
Zheng, X	1
Guan, L	1
Jiang, Z	1
Lin, H	1
Jiang, Q	1
Zhang, N	1
Yu, C	2
Guan, Q	1
van Tienhoven-Wind, LJ	2
Dullaart, RP	2
Ludwig, U	1
Holzner, D	1
Denzer, C	1
Greinert, A	1
Haenle, MM	1
Oeztuerk, S	1
Koenig, W	1
Boehm, BO	1
Mason, RA	1
Kratzer, W	1
Graeter, T	1
Lee, KW	1
Bang, KB	1
Rhee, EJ	1
Kwon, HJ	1
Lee, MY	1
Cho, YK	1
Gökmen, FY	1
Ahbab, S	1
Ataoğlu, HE	1
Türker, BÇ	1
Çetin, F	1
Türker, F	1
Mamaç, RY	1
Yenigün, M	1
Geach, T	1
van den Berg, EH	1
Amini, M	1
Schreuder, TC	1
Faber, KN	1
Blokzijl, H	1
Xu, C	1
Xu, L	1
Miao, M	1
Walsh, JP	1
Chung, GE	1
Kim, D	1
Kim, W	1
Yim, JY	1
Park, MJ	1
Kim, YJ	1
Yoon, JH	1
Lee, HS	1